Latest / Inside Startup Investing with Chris Lustrino
Rejuvenate Bio CEO on Gene Therapy for Aging Pets and Humans
Rejuvenate Bio CEO Dan Oliver joins Chris Lustrino to discuss the company’s gene therapy platform for aging-related disease. A spinout from George Church’s lab at Harvard Medical School, Rejuvenate Bio is developing therapies designed to change gene expression profiles associated with aging rather than edit or replace a patient’s underlying genome. Dan explains how the company uses viral delivery to help the body produce beneficial proteins over time.
The conversation explores Rejuvenate Bio’s dual strategy across animal health and human health. Dan explains why dogs offer both a meaningful…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.